Pinney & Scofield’s AbbVie ABBV Stock Holding History

Pinney & Scofield’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104K	Hold	478	–	–	0.06%	78
2025 Q4	$109K	Sell	478 -10	-2%	-$2.28K	0.06%	75
2025 Q3	$113K	Hold	488	–	–	0.07%	70
2025 Q2	$90.6K	Buy	488 +288	+144%	+$53.5K	0.06%	78
2025 Q1	$41.9K	Hold	200	–	–	0.03%	106
2024 Q4	$35.5K	Buy	+200	New	+$36.8K	0.03%	112

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pinney & Scofield's ABBV Position: Q1 2026 in Review

Pinney & Scofield held its AbbVie (ABBV) position steady in Q1 2026 at 478 shares worth $104K. The position accounts for 0.06% of the portfolio, ranked #78.

Pinney & Scofield first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $113K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pinney & Scofield held 478 shares of AbbVie worth $104K as of Q1 2026.
Pinney & Scofield left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.06% of Pinney & Scofield's portfolio in Q1 2026, its #78 holding.
Pinney & Scofield first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Pinney & Scofield's AbbVie position peaked at $113K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pinney & Scofield's 13F filing for Q1 2026, filed 15 May 2026.